We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BDR Pharma

News List

BDR Pharma launches generic version of Lenvatinib in India expresspharma
October 22, 2020
It is indicated for the treatment of differentiated thyroid cancer, advanced liver cancer and advanced kidney cancer.
BDR Pharma launches Nintenib (Nintedanib) to treat idiopathic pulmonary fibrosis in India expresspharma
October 21, 2020
BDR Pharma announced the launch of 100 mg and 150 mg Nintedanib under the brand name Nintenib for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment expresspharma
September 22, 2020
It reduces the pill burden and expected to increase the patient compliance.
BDR Pharma to launch 400 mg Favipiravir tablets expresspharma
September 07, 2020
BDR Pharmaceuticals said it plans to launch 400 mg Favipiravir tablets, used for treating COVID-19 patients, in the country.